Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 6 | 9 | 39 | 6 |
| Receivables | N/A | N/A | 4 | 6 | 6 |
| TOTAL | $1 | $7 | $15 | $46 | $12 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 234 | 236 | 237 |
| Investments And Advances | 14 | 11 | 13 | 29 | 54 |
| Intangibles | 0 | 0 | 2,991 | 0 | 0 |
| TOTAL | $14 | $11 | $3,238 | $265 | $291 |
| Total Assets | $15 | $17 | $3,252 | $312 | $303 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 129 | 150 | 369 | 260 | 138 |
| Accounts payable and accrued liabilities | 263 | 241 | 192 | 178 | 155 |
| Accrued Expenses | 83 | 63 | 52 | 41 | 35 |
| TOTAL | $753 | $732 | $663 | $494 | $344 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69 | 69 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 72 | 60 | 51 | 45 | 34 |
| TOTAL | $141 | $128 | $51 | $45 | $34 |
| Total Liabilities | $894 | $860 | $713 | $540 | $377 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,284 | 38,784 | 31,521 | 10,023 | 9,903 |
| Common Shares | 37 | 34 | 32 | 10 | 10 |
| Retained earnings | -3,819 | -3,502 | -84 | -4,860 | -4,650 |
| Other shareholders' equity | 3 | 0 | -4 | -6 | 19 |
| TOTAL | $-879 | $-843 | $2,539 | $-228 | $-74 |
| Total Liabilities And Equity | $15 | $17 | $3,252 | $312 | $303 |